RAJINDER SHIWACH: Open Payments
NPI 1992740278 · DESOTO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 12 payments from 8 companies in 2025. Trend: 2023 $4,748 · 2024 $72 · 2025 $634
Food & beverage: $417Travel & lodging: $217
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $241 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $105 |
| ABBVIE INC. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: INVEGA SUSTENNA, VRAYLAR, AUSTEDO XR, INGREZZA, CAPLYTA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
